A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Pengxuan Ren, Weijuan Shang, Wanchao Yin, Huan Ge, Lin Wang, Xiang-lei Zhang, Bingqian Li, Honglin Li, Yechun Xu, H. Eric Xu, Hualiang Jiang, Li-li Zhu, Leike Zhang, Fang Bai
Topics & Concepts
DrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Drug discoveryPharmacology2019-20 coronavirus outbreakDrug repositioningMedicineDrug developmentComputational biologyVirologyBiologyBioinformaticsInfectious disease (medical specialty)DiseaseInternal medicineOutbreakComputational Drug Discovery MethodsSynthesis and biological activitySARS-CoV-2 and COVID-19 Research